NLRP3 and COVID-19: So far, several studies have reported hyperactivation of the NLRP3 inflammasome in COVID-19, as well as its relation to pathologies associated with severe COVID-19 such as acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) [24,26].